ALNYLAM PHARMACEUTICALS, INC. Receivables, Net, Current
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Receivables, Net, Current of $2.96 million as of 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Balance Sheet › Assets
us-gaap:ReceivablesNetCurrent · last filed 2018-08-02
- 2018-06-30: Receivables, Net, Current $2.96M.
- 2018-03-31: Receivables, Net, Current $50.77M.
- 2017-12-31: Receivables, Net, Current $34.00M.
- 2017-09-30: Receivables, Net, Current $14.64M.
| Period end | Receivables, Net, Current |
|---|---|
| 2018-06-30 | $2.96M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $50.77M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $34.00M 10-Q · filed 2018-08-02 |
| 2017-09-30 | $14.64M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $15.40M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $19.46M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $23.33M 10-K · filed 2018-02-15 |
| 2016-09-30 | $15.15M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $9.51M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $8.81M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $8.30M 10-K · filed 2017-02-15 |
| 2015-09-30 | $8.13M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $9.40M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $10.11M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $39.94M 10-K · filed 2016-02-12 |
| 2014-09-30 | $384.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $89.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $164.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $4.25M 10-K · filed 2015-02-13 |
| 2013-09-30 | $609.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $460.00K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $558.00K 10-Q · filed 2013-05-07 |
| 2012-12-31 | $104.00K 10-K · filed 2014-02-20 |
| 2012-09-30 | $1.92M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $4.38M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $2.19M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $1.47M 10-K · filed 2013-02-19 |
| 2011-09-30 | $2.03M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $1.31M 10-Q · filed 2011-08-03 |
| 2011-03-31 | $1.15M 10-Q · filed 2011-05-05 |
| 2010-12-31 | $3.45M 10-K · filed 2012-02-13 |
| 2010-09-30 | $4.88M 10-Q · filed 2010-11-04 |
| 2010-06-30 | $6.36M 10-Q · filed 2010-08-05 |
| 2009-12-31 | $6.04M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |